Ann C. Childress, MD
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada
Original Research
Amphetamine Extended-Release Tablets for Adult ADHD
July 20, 2022
Treating attention-deficit/hyperactivity disorder (ADHD) in adults can improve long-term outcomes, such as reducing suicidal behavior and mortality. This study evaluated the efficacy and safety of amphetamine extended-release tablets in...
Original Research
Response and Remission with DR/ER-MPH
June 22, 2021
Delayed-release and extended-release methylphenidate (DR/ER-MPH) has shown marked improvement in ADHD symptoms and functional impairment. This post hoc analysis examined response and remission thresholds for DR/ER-MPH in the context...
Article
Treating Attention-Deficit/Hyperactivity Disorder in Adults: Focus on Once-Daily Medications
November 17, 2011
The objective of this study is to review the efficacy, safety, and abuse potential of approved treatments in adults with attention-deficit/hyperactivity disorder, with a focus on once-daily medications.
